PTEN Inhibits High Glucose-Induced Phenotypic Transition in Podocytes

Lingling Xing1,2, Qingjuan Liu1, Shuxia Fu2

  • 1Department of Pathology, Hebei Medical University, Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, Hebei, 050017, China.

Insights

High glucose activates the PTEN/PI3K/Akt pathway in kidney podocytes, driving diabetic nephropathy progression. Inhibiting this pathway prevents harmful cellular changes, offering potential therapeutic targets.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Diabetic nephropathy (DN) is a leading cause of kidney failure.
  • Podocyte injury, including epithelial-mesenchymal transition (EMT), is a hallmark of DN.
  • The precise molecular mechanisms driving podocyte EMT in DN remain unclear.

Purpose of the Study:

  • To investigate the role of the Phosphatidylinositol 3-kinase/Protein kinase B (PI3K/Akt) pathway in high glucose-induced podocyte EMT.
  • To identify key molecular players involved in this process.

Main Methods:

  • Cultured podocytes were exposed to high glucose conditions.
  • Activation of the PI3K/Akt pathway was assessed.
  • Expression levels of podocyte markers (podocalyxin, nephrin) and EMT markers (desmin, α-smooth muscle actin) were measured.
  • The effects of PI3K/Akt pathway inhibition (using LY294002 or PTEN) were evaluated.

Main Results:

  • High glucose activated the PI3K/Akt pathway in podocytes.
  • This activation correlated with decreased expression of podocalyxin and nephrin.
  • Concurrently, desmin and α-smooth muscle actin expression increased, indicating EMT.
  • Inhibition of the PI3K/Akt pathway using LY294002 or PTEN reversed these phenotypic changes.

Conclusions:

  • The PTEN/PI3K/Akt pathway is a critical mediator of high glucose-induced EMT in podocytes.
  • Targeting this pathway may offer a therapeutic strategy for diabetic nephropathy.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.4K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K